The top companies in the pharmaceutical industry are amongst the most profitable businesses in the world. The largest pharmaceutical companies hold the rights to drugs worth many billions of dollars a year.

So how do these major pharmaceutical companies earn their money? It certainly isn’t by finding miracle cures! The ‘holy grail’ of the pharmaceuticals industry are drugs that treat (but not cure) the symptoms of some of the most common chronic conditions so that continued drug use is required throughout a patient’s life.

And if you think the pharmaceuticals industry is run on an ethical basis, then think again!

Marketing and PR are by far the biggest costs for these multinational pharmaceutical companies. They spend only about half as much on ”research”, including clinical trials, to justify the use of these drugs. And the studies may be structured in such a way as to exclude data (such as patient death) which won’t look good in the results. You just have to learn a little about the suppressed data and biased analysis that allows drugs to pass the regulatory tests, to know that it’s the bucks that count, not the patients health and well-being!

The release of the drug is not the end of the drug trial period. The first years of a drug’s release are also used to assess the drug, during which time many more side effects may come to light. People don’t realize that they are acting as guinea pigs and that the medicine they’re taking hasn’t been studied for effects of long term usage. Drug companies allocate a huge fund for out-of-court compensation payments for the problems that emerge during this testing in the market place.

Once the drug company has amassed the positive “evidence” for a drug, experts are offered substantial incentives to validate the research and, similarly, regulators may be incentivized to expedite the release of the drugs. Incidentally, the regulators view the drug companies as their customers, not the public, and it is the customer they wish to keep happy!  Once approved, the drug companies then focus huge resources to get health care professionals to prescribe their drug in preference to another.

The same experts that are funded by the drug companies also sit on the committees that set the levels at which it is recommended that symptoms/conditions should be treated. The lower the thresholds are set, the greater the number of patients treated and the more revenue the drug companies earn – some of which then ends up in the experts’ pockets.

Learn more about how pharmaceutical companies control almost every aspect of the pharmaceutical industry, including influencing the supposed watchdogs! Get to grips with just how ineffective some of the top-selling, highest-earning prescription medications really are.

Now that we are in the know, we will never take a prescription medicine without first of all researching it. Once you’ve read the articles about how a pharmaceutical company operates, you may feel the same!

DISCLAIMERS:

Please seek professional medical advice when considering any new course of treatment. Be aware that different treatments may affect individuals in a variety of ways and that what works for one person may not work for another. Likewise a medicine that causes problems for one person may produce good results for another and remember that some medications may interact with other drugs and even food stuffs.

The comments posted on this site represent the views of individuals and do not constitute our endorsement of any product or service. Whilst we have made every effort to ensure that the articles published on this site are accurate and supported by research, they are for information purposes only and do not constitute a recommendation and should not be relied upon when making desicions about your health care.

We do not take responibility for the material posted on our websites by our contributors, nor for any comments, remarks and opinions that may be posted anywhere on this website. Any such contribututions, comments, remarks and opinions should not be considered to be representative of the views of the websites’, hosts, owners and operators.